Explant rates of neuromodulation devices: supplemental information—reply to Mukhdomi and Harris
| Autor: | Thomas L. Yearwood, Adnan Al-Kaisy, Nicholas Padfield, Jonathan Royds, Tom Smith, Stefano Palmisani, Samuel Wesley, Stephany Harris, Stephen Ward, David Pang, Omar Al-Kaisy |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry Chronic pain General Medicine Spinal cord stimulation Pain management medicine.disease Neuromodulation (medicine) 03 medical and health sciences 0302 clinical medicine Anesthesiology and Pain Medicine Physical medicine and rehabilitation 030202 anesthesiology medicine Back pain medicine.symptom business 030217 neurology & neurosurgery |
| Zdroj: | Regional Anesthesia & Pain Medicine. :rapm-2020 |
| ISSN: | 1532-8651 1098-7339 |
| DOI: | 10.1136/rapm-2020-102410 |
| Popis: | To the Editor We would like to thank the authors for their response to our article and appreciate the opportunity to discuss our study further.[1][1] We have addressed the issues raised in a point by point response. Only n=2 (2/1177, 0.2%) of our electrical neuromodulation devices were explanted |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|